POOLED ANALYSIS OF OBJECTIVE COUGH FREQUENCY IN PARTICIPANTS WITH CHRONIC COUGH TREATED WITH GEFAPIXANT IN TWO PHASE 3 CLINICAL TRIALS (COUGH-1 AND COUGH-2)

被引：1
|
作者：
Smith, J. A. [1 ,2 ]
Morice, A. [3 ]
McGarvey, L. [4 ]
Pavord, I. [5 ]
Birring, S. S. [6 ]
Dicpinigaitis, P. [7 ,8 ]
Iskold, B. [9 ]
Li, Q. [9 ]
Tzontcheva, A. [9 ]
La Rosa, C. [9 ]
Muccino, D. [9 ]
机构：
[1] Univ Manchester, Div Infect, Immun & Resp Med, Manchester, Lancs, England
[2] Manchester Univ NHS Trust, Div Infect, Immun & Resp Med, Manchester, Lancs, England
[3] Hull York Med Sch, Cottingham, England
[4] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland
[5] Univ Oxford, Nuffield Dept Med, Oxford NIHR Resp BRC, Oxford, England
[6] Kings Coll London, Sch Basic & Med Biosci, Fac Life Sci & Med, Ctr Human & Appl Physiol Sci, London, England
[7] Albert Einstein Coll Med, Bronx, NY USA
[8] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
[9] Merck & Co Inc, Kenilworth, NJ USA
来源：
THORAX | 2021年 / 76卷
关键词：
D O I：
10.1136/thorax-2021-BTSabstracts.171
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P61
引用
收藏
页码：A99 / A100
页数：2
相关论文
共 50 条
  • [41] Early cough severity changes over the first 4 weeks of treatment with gefapixant in two phase 3 studies
    Morice, A. H.
    Birring, S. S.
    Dicpinigaitis, P.
    Li, Q.
    Urdaneta, E.
    Philip, G.
    La Rosa, C.
    THORAX, 2023, 78 (SUPPL_4) : A7 - A8
  • [42] Characterization of chronic cough patients participating in a phase 2b clinical trial of gefapixant, a P2X3 receptor antagonist
    McGarvey, Lorcan
    Smith, Jaclyn
    Birring, Surinder
    Morice, Alyn
    Sher, Mandel
    Wu, Wen-Chi
    Muccino, David
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [43] Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough
    V. Dicpinigaitis, Peter
    Birring, Surinder S.
    Blaiss, Michael
    McGarvey, Lorcan P.
    Morice, Alyn H.
    Pavord, Ian D.
    Satia, Imran
    Smith, Jaclyn A.
    La Rosa, Carmen
    Li, Qing
    Nguyen, Allison Martin
    Schelfhout, Jonathan
    Tzontcheva, Anjela
    Muccino, David
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 130 (01) : 60 - 66
  • [44] Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant
    Morice, Alyn H.
    Birring, Surinder S.
    Smith, Jaclyn A.
    McGarvey, Lorcan P.
    Schelfhout, Jonathan
    Martin Nguyen, Allison
    Xu, Zhi Jin
    Wu, Wen-Chi
    Muccino, David R.
    Sher, Mandel R.
    LUNG, 2021, 199 (02) : 121 - 129
  • [45] Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant
    Alyn H. Morice
    Surinder S. Birring
    Jaclyn A. Smith
    Lorcan P. McGarvey
    Jonathan Schelfhout
    Allison Martin Nguyen
    Zhi Jin Xu
    Wen-Chi Wu
    David R. Muccino
    Mandel R. Sher
    Lung, 2021, 199 : 121 - 129
  • [46] BASELINE CHARACTERISTICS AND MEDICAL HISTORY OF PATIENTS WITH REFRACTORY OR UNEXPLAINED CHRONIC COUGH PARTICIPATING IN TWO GLOBAL PHASE 3 CLINICAL TRIALS
    McGarvey, L.
    Birring, S. S.
    Dicpinigaitis, P.
    Morice, A.
    Pavord, I.
    Smith, J. A.
    Iskold, B.
    Li, Q.
    Nguyen, A. Martin
    Schelfhout, J.
    Tzontcheva, A.
    La Rosa, C.
    Muccino, D.
    THORAX, 2021, 76 : A98 - A99
  • [47] P2X3-selective mechanism of Gefapixant, a drug candidate for the treatment of refractory chronic cough
    Cui, Wen-Wen
    Wang, Si-Yu
    Zhang, Yu-Qing
    Wang, Yao
    Fan, Ying-Zhe
    Guo, Chang-Run
    Li, Xing-Hua
    Lei, Yun-Tao
    Wang, Wen-Hui
    Yang, Xiao-Na
    Hattori, Motoyuki
    Li, Chang-Zhu
    Wang, Jin
    Yu, Ye
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 1642 - 1653
  • [48] A Phase 3b Trial to Evaluate the Efficacy and Safety of Gefapixant in Adults with Recent-Onset Chronic Cough
    Mcgarvey, L.
    Sher, M. R.
    Afzal, A. Sadaf
    La Rosa, C.
    Muccino, D.
    Nguyen, A. Martin
    Schelfhout, J.
    Wu, W.
    Xu, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [49] A Phase 3b Trial Evaluating the Efficacy of Gefapixant in Reducing Stress Urinary Incontinence in Women with Chronic Cough
    Birring, S.
    Cardozo, L.
    Dmochowski, R.
    La Rosa, C.
    Afzal, A. S.
    Nguyen, A. M.
    Schelfhout, J.
    Xu, P.
    Lu, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [50] Safety and efficacy of gefapixant, a novel drug for the treatment of chronic cough: A systematic review and meta-analysis of randomized controlled trials
    Abu-Zaid, Ahmed
    Aljaili, Aseel Khalid
    Althaqib, Amnah
    Adem, Fatima
    Alhalal, Doaa Ali
    Almubarak, Amena Faiq
    Aldughaither, Saud Musaab
    Alghabban, Sarah Ali
    Alfaraj, Ghaidaa
    Masoud, Ahmed Taher
    Alsuhaibani, Nujud Abdullah
    ANNALS OF THORACIC MEDICINE, 2021, 16 (02) : 127 - 140
12345